BrUOG 299: Ixazomib, Oral Metronomic Cyclophosphamide and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Ixazomib (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms BrUOG 299
- 01 Sep 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 14 Apr 2015 New trial record